共 101 条
[21]
Yamasaki K(2016)Serum Medicine (Baltimore) 95 e3328-666
[22]
Tateyama M(2002) agglutinin-positive Mac-2 binding protein values predict the development of hepatocellular carcinoma among patients with chronic hepatitis C after sustained virological response J Clin Microbiol 40 439-21719
[23]
Abiru S(2003)Clinical implication of serum WFA+-M2BP level on hepatitis B e antigen loss or seroconversion in hepatitis B e antigen-positive patients J Viral Hepat 10 324-1106
[24]
Umemura T(2006)WFA(+) -M2BP: a novel biomarker with diagnostic and therapeutic implications in liver diseases Hepatol Res 36 272-36
[25]
Joshita S(2007)Clinical implication of serum Hepatol Res 37 661-9
[26]
Sekiguchi T(2005) agglutinin-positive Mac-2-binding protein in treatment naïve chronic hepatitis B J Biol Chem 280 21713-468
[27]
Toshima T(2016)Serum WFA(+) -M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection J Infect Dis 213 1096-145
[28]
Shirabe K(2007) agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development Hepatology 46 32-647
[29]
Ikegami T(2014)Use of Curr Opin Virol 8 1-182
[30]
Nishikawa H(2015) agglutinin-positive human Mac-2 binding protein in assessing risk of hepatocellular carcinoma due to hepatitis B virus Clin Res Hepatol Gastroenterol 39 458-190